Company page

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. (Ticker: LXEO) is a public company based in the United States, specializing in innovative therapies. With a market capitalization of approximately $387 million, Lexeo is focused on advancing its research and development efforts in the biopharmaceutical sector. The company aims to address unmet medical needs through its cutting-edge therapeutic solutions.